156 related articles for article (PubMed ID: 30383199)
1. Semaphorin 3F Modulates Corneal Lymphangiogenesis and Promotes Corneal Graft Survival.
Reuer T; Schneider AC; Cakir B; Bühler AD; Walz JM; Lapp T; Lange C; Agostini H; Schlunck G; Cursiefen C; Reinhard T; Bock F; Stahl A
Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5277-5284. PubMed ID: 30383199
[TBL] [Abstract][Full Text] [Related]
2. Vascular Endothelial Growth Factor Receptor 1 morpholino increases graft survival in a murine penetrating keratoplasty model.
Cho YK; Zhang X; Uehara H; Young JR; Archer B; Ambati B
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8458-71. PubMed ID: 23150613
[TBL] [Abstract][Full Text] [Related]
3. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.
Bachmann BO; Bock F; Wiegand SJ; Maruyama K; Dana MR; Kruse FE; Luetjen-Drecoll E; Cursiefen C
Arch Ophthalmol; 2008 Jan; 126(1):71-7. PubMed ID: 18195221
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.
Hos D; Bock F; Dietrich T; Onderka J; Kruse FE; Thierauch KH; Cursiefen C
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1836-42. PubMed ID: 18436817
[TBL] [Abstract][Full Text] [Related]
5. Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation.
Bachmann BO; Luetjen-Drecoll E; Bock F; Wiegand SJ; Hos D; Dana R; Kruse FE; Cursiefen C
Br J Ophthalmol; 2009 Aug; 93(8):1075-80. PubMed ID: 19224901
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.
Hou Y; Le VNH; Clahsen T; Schneider AC; Bock F; Cursiefen C
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5862-5869. PubMed ID: 29145577
[TBL] [Abstract][Full Text] [Related]
7. Effect of glucocorticoid (triamcinolone acetonide) pretreatment in a murine penetrating keratoplasty and suture model.
Cho YK; Uehara H; Young JR; Archer B; Ambati BK
Cornea; 2012 Dec; 31(12):1468-75. PubMed ID: 22677639
[TBL] [Abstract][Full Text] [Related]
8. Intracellular thiol redox status regulates lymphangiogenesis and dictates corneal limbal graft survival.
Fukumoto A; Maruyama K; Walsh T; Kajiya K; Hamuro J; D'Amore PA; Kinoshita S
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2450-8. PubMed ID: 20042658
[TBL] [Abstract][Full Text] [Related]
9. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.
Bucher F; Parthasarathy A; Bergua A; Onderka J; Regenfuss B; Cursiefen C; Bock F
Acta Ophthalmol; 2014 Mar; 92(2):143-8. PubMed ID: 22994268
[TBL] [Abstract][Full Text] [Related]
10. Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis.
Hos D; Bachmann B; Bock F; Onderka J; Cursiefen C
Exp Eye Res; 2008 Nov; 87(5):427-32. PubMed ID: 18755186
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.
Lin T; Gong L
Drug Des Devel Ther; 2017; 11():1147-1158. PubMed ID: 28435226
[TBL] [Abstract][Full Text] [Related]
12. Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.
Bock F; Onderka J; Dietrich T; Bachmann B; Pytowski B; Cursiefen C
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):115-9. PubMed ID: 17909835
[TBL] [Abstract][Full Text] [Related]
13. [Anti(lymph)angiogenic preconditioning prior to keratoplasty].
Cursiefen C; Regenfuss B; Hos D; Bucher F; Steven P; Heindl LM; Bock F
Klin Monbl Augenheilkd; 2013 May; 230(5):500-4. PubMed ID: 23695846
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis.
Zhang B; Gao Z; Sun M; Li H; Fan H; Chen D; Zheng J
J Surg Oncol; 2015 Mar; 111(4):382-8. PubMed ID: 25475162
[TBL] [Abstract][Full Text] [Related]
15. Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma.
Doçi CL; Mikelis CM; Lionakis MS; Molinolo AA; Gutkind JS
Cancer Res; 2015 Jul; 75(14):2937-48. PubMed ID: 25952650
[TBL] [Abstract][Full Text] [Related]
16. Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival.
Emami-Naeini P; Dohlman TH; Omoto M; Hattori T; Chen Y; Lee HS; Chauhan SK; Dana R
Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1755-62. PubMed ID: 25091513
[TBL] [Abstract][Full Text] [Related]
17. Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids.
Hos D; Saban DR; Bock F; Regenfuss B; Onderka J; Masli S; Cursiefen C
Arch Ophthalmol; 2011 Apr; 129(4):445-52. PubMed ID: 21482870
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.
Bock F; Onderka J; Dietrich T; Bachmann B; Kruse FE; Paschke M; Zahn G; Cursiefen C
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2545-52. PubMed ID: 17525183
[TBL] [Abstract][Full Text] [Related]
19. [Anti(lymph)angiogenic Strategies to Improve Corneal Graft Survival].
Bock F; Cursiefen C
Klin Monbl Augenheilkd; 2017 May; 234(5):674-678. PubMed ID: 28505675
[TBL] [Abstract][Full Text] [Related]
20. Netrin-4 Mediates Corneal Hemangiogenesis but Not Lymphangiogenesis in the Mouse-Model of Suture-Induced Neovascularization.
Maier AB; Klein S; Kociok N; Riechardt AI; Gundlach E; Reichhart N; Strauß O; Joussen AM
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1387-1396. PubMed ID: 28253401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
